Cutis Clinic offers an highly effective 20-week re-pigmentation program designed to re-pigment the white patches so noticeable in vitiligo-affected skin. This program consists of two components. During your initial consultation your specialist dermatologist will prescribe you a combination of topical prescription creams to help reduce skin inflammation. The second component is the use of medically-prescribed phototherapy to help kick-start the pigment-producing cells in your skin.
- Your vitiligo re-pigmentation program can add pigment to the typical white patches of vitiligo
- This 20-week program has a re-pigmentation success rate of 80%
- Early vitiligo intervention ensures a higher success rate; patches on the face and neck respond best with the hands and feet more resistant to treatment
- Your Cutis Clinic dermatologist will provide a tailor-made a prescription and set up a custom protocol based upon your specific vitiligo condition
- 2-3 phototherapy sessions per week (at evenly-spaced intervals) kick-start your pigment-producing cells in pale patches of skin
- If eligible, Cutis phototherapy sessions are bulk-billed via Medicare. A valid referral is required to ensure your phototherapy sessions are covered
The science behind our vitiligo program is based upon the very latest in technology and research. Our re-pigmentation program uses a combination of topical prescription creams and narrowband UVB phototherapy. Prescription creams help reduce skin inflammation and phototherapy awakens the pigment-producing cells within the skin. The majority of vitiligo sufferers will start to notice areas of re-pigmentation within a few weeks of following this program.
Providing treatments tailored according to each patient’s skin type, location and extent of skin disorder is central to Cutis Clinic. In the case of vitiligo, this personalisation has led to our 80% success rate in the re-pigmentation of vitiligo-affected skin. Most patients notice re-pigmentation within 4-6 weeks of this program.
We cannot predict with absolute certainty as to who will respond best to our vitiligo treatments; however, as a guide:
- Excellent responders: early intervention, small patches, face vitiligo, neck vitiligo
- Good responders: intermediate vitiligo, intermediate sized vitiligo patches
- Poor responders: long-standing vitiligo, white areas on the hands and feet
The need for further treatment after this 20-week program will naturally depend on how successful your treatment regime has been.
80% of patients will experience a moderate to excellent response to the program, although we advise you continue phototherapy until your pigmentation is stable. The lifetime phototherapy limit is 350 treatments for lighter skin types and up to 700 treatments for darker skin. Phototherapy sessions are bulk-billed for eligible patients with a valid referral through Medicare.
20% of patients fail to achieve re-pigmentation despite following the 20-week program. In this subgroup, we recommend blending creams to help reduce the visible signs of this condition.
No. This program is only suitable for children over 8 years of age. Our practice policy does not recommend phototherapy for children with vitiligo. Paediatric populations are placed on topical presciption creams aimed at reducing inflammation and stimulating re-pigmentation.
Our specialist paediatric dermatologists who have much experience in paediatric vitiligo are Dr. Belle Cominos, Dr. Paul Teng, Dr. Shiva Baghaei and Dr. Tania Zappala.
Call reception on (07) 3088 6985 to discuss the referral process and appointment times.
This program is suitable for the majority of vitiligo cases.
Even so, a small group are excluded from our re-pigmenting program. These include:
- Patients with a personal or direct family history of melanoma
- Patients with a history of photosensitive skin disorders such as lupus
- Patients unable to attend at least 2 sessions of phototherapy per week
- Children under the age of 8.
An assessment by a consultant dermatologist is necessary prior to the commencement of your vitiligo treatment. During an initial consultation, Cutis Clinic dermatologists assess the extent of your vitiligo, conduct any necessary tests and then provide you with a individual treatment plan. We will also discuss the potential prognosis. Baseline photographs will be taken during your initial consultation and will give both you and our doctors a good indication of your progress.
For adult cases of vitiligo: please make an appointment with Dr Davin Lim
For paediatric cases of vitiligo (up to 8 years of age): please make an appointment with Dr Paul Teng or Dr Heba Jibreal
For more information on the referral process, call reception on (07) 3088 6985
*Inter-state patients: Discuss a referral to a dermatologist who provides phototherapy treatment for vitiligo in your state with your GP
An initial consultation with a dermatologist is required prior to commencement of treatment.
Please contact us for pricing.
Narrowband Phototherapy is fully covered by Medicare with no additional costs for the patient. International patients will need to consult their private health care provider to determine if narrowband UVB phototherapy is included (quote item number 14050).
Private health insurance provides a partial rebate for vitiligo creams. In some cases, these creams are covered by the PBS.
Dr Davin S. Lim
Cutis Clinic’s Vitiligo Re-pigmentation Program is based upon the very latest research. The foundation of this program is the application of anti-inflammatory creams in combination with regular phototherapy sessions. In tandem, both components have a much greater success rate in the return of pigment to white patches of vitiligo-affected skin. The highest success rates are for cases of early vitiligo of the face and neck . Long-standing vitiligo on the hands and feet responds poorly to treatment; however, some of these cases have had success on our program.
If re-pigmentation is achieved at 20 weeks, patients are encouraged to continue with maintenance phototherapy. Cutis Clinic bulk-bills phototherapy sessions whenever a patient is eligible for medical insurance cover.